AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia

Added 518 days ago (15.12.2020)
Authors: Balachander, S. B., Criscione, S. W., Byth, K. F., Cidado, J., Adam, A., Lewis, P., Macintyre, T., Wen, S., Lawson, D., Burke, K., Lubinski, T., Tyner, J. W., Kurtz, S. E., McWeeney, S. K., Varnes, J., Diebold, R. B., Gero, T., Ioannidis, S., Hennessy, E. J., McCoull, W., Saeh, J. C., Tabatabai, A., Tavana, O., Su, N., Schuller, A., Garnett, M. J., Jaaks, P., Coker, E. A., Gregory, G. P., Newbold, A., Johnstone, R. W., Gangl, E., Wild, M., Zinda, M., Secrist, J. P., Davies, B. R., Fawell, S. E., Gibbons, F. D.
Read article